According to a study published in the December issue of The BMJ, people who believe in conspiracies, oppose the covid-19 vaccine, or prefer alternative medicine are more likely to support mythical causes of cancer than non-conspiracists, but less likely to support actual causes of cancer.
According to a research published in the journal 'Scientific Reports' bacterial therapeutics mixed with other therapy modalities could increase treatment efficacy while minimizing side effects.
The sympathetic nervous system tumour known as neuroblastoma mainly affects young children. In the Netherlands, 25 kids are given this diagnosis per year. An essential component of the therapy strategy is surgery to remove the tumour tissue. Since November 2014, the Princess Maxima Center fo
People with blood cancer usually have a weak immune system, putting them at an increased risk of becoming very ill from COVID-19. Furthermore, several cancer treatments cause these individuals to develop little or no antibodies against SARS-CoV-2 after COVID-19 vaccination.
Researchers from UConn Health, Yale, and Johns Hopkins discovered that some cancer cells can "cheat" by evading the limits imposed by a lack of oxygen, allowing the cancer cells to grow.
Cancer-causing gene mutation KRAS, found in nearly 30 per cent of all human tumours, successfully shrunk tumours or stopped cancer growth in preclinical models of pancreatic cancer.
Basal-like breast cancers, also known as triple-negative cancers, are a particularly aggressive subtype of breast cancer with limited treatment options. Although the origin of luminal (cells that line the surface of the breast duct) and basal subtypes of breast cancer is unknown, studies sug
Researchers from the University of Pittsburgh have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy.
In a new study, researchers from UC San Francisco and Vanderbilt University Medical Center identified particular immune cells that cause lethal cardiac damage in a small subsection of cancer immunotherapy patients.
Scientists have identified a drug that could be a game-changer for patients. Istradefylline, which is already approved for Parkinson's disease, could reduce not only the harmful effects of cisplatin but also improve its anti-tumour properties.
A ground-breaking discovery by a multinational team led by Penn State researchers has given new hope against malaria, which kills over 500,000 people each year, disproportionately impacting children under the age of five, pregnant women, and HIV patients.
Washington [US], October 23 (ANI): Researchers have successfully 3D bioprinted breast cancer tumours and treated them in a breakthrough study to better understand the disease that is one of the leading causes of mortality worldwide.